- Home
- LPSN vs FBRX Comparison
LPSN vs FBRX Comparison
Compare LPSN & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- FBRX
- Stock Information
- Founded
- LPSN 1995
- FBRX N/A
- Country
- LPSN United States
- FBRX United States
- Employees
- LPSN N/A
- FBRX N/A
- Industry
- LPSN EDP Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- FBRX Health Care
- Exchange
- LPSN Nasdaq
- FBRX Nasdaq
- Market Cap
- LPSN 122.6M
- FBRX 125.9M
- IPO Year
- LPSN 2000
- FBRX N/A
- Fundamental
- Price
- LPSN $1.36
- FBRX $14.70
- Analyst Decision
- LPSN Hold
- FBRX Strong Buy
- Analyst Count
- LPSN 6
- FBRX 4
- Target Price
- LPSN $1.18
- FBRX $77.58
- AVG Volume (30 Days)
- LPSN 7.8M
- FBRX 61.1K
- Earning Date
- LPSN 02-26-2025
- FBRX 11-14-2024
- Dividend Yield
- LPSN N/A
- FBRX N/A
- EPS Growth
- LPSN N/A
- FBRX N/A
- EPS
- LPSN N/A
- FBRX N/A
- Revenue
- LPSN $334,736,000.00
- FBRX N/A
- Revenue This Year
- LPSN N/A
- FBRX N/A
- Revenue Next Year
- LPSN N/A
- FBRX N/A
- P/E Ratio
- LPSN N/A
- FBRX N/A
- Revenue Growth
- LPSN N/A
- FBRX N/A
- 52 Week Low
- LPSN $0.45
- FBRX $4.11
- 52 Week High
- LPSN $3.29
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- LPSN 57.45
- FBRX 39.02
- Support Level
- LPSN $1.27
- FBRX $13.82
- Resistance Level
- LPSN $1.43
- FBRX $17.81
- Average True Range (ATR)
- LPSN 0.22
- FBRX 2.76
- MACD
- LPSN -0.01
- FBRX -0.98
- Stochastic Oscillator
- LPSN 33.33
- FBRX 7.24
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation.. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).